International CAR-T Cell Therapy and Cancer Immunotherapy Services for Global Patients (Without the Complexity of Navigating Overseas Healthcare)

Core Clinical Features

• Advanced CAR-T cell therapy for relapsed or refractory B-cell malignancies.
• Comprehensive cancer screening packages (Bronze, Silver, Gold, Diamond) with extensive tumor markers.
• Specialized endoscopy services utilizing Blue Laser Imaging (BLI) and Linked Color Imaging (LCI).
• FotoFinder digital skin mapping system for early melanoma interception.
• Personalized oncology planning utilizing a multidisciplinary team approach to evaluate complex cases.

Reliability & Control

• Member unit of the prestigious Ruijin Hematology Medical Union.
• Construction unit of the Pan-Yangtze River Delta CAR-T Cell Therapy Alliance.
• Strict adherence to international endocrine and oncological clinical guidelines.
• Quality management and clinical training collaboration with Mayo Clinic.
• Continuous medical supervision incorporating early cancer detection protocols such as precise biopsies.

Integrations & Support

• Dedicated international patient support desk with multilingual translation services.
• Direct billing with major international insurance providers for seamless payment.
• Comprehensive medical travel assistance, including visa support and airport transfers.
• Post-discharge care coordination and secure telehealth follow-ups.
• Seamless integration with other specialties, including specialized hormone therapy and wellness programs.

What is CAR-T cell therapy and how does it work?

CAR-T cell therapy, or Chimeric Antigen Receptor T-cell therapy, is a revolutionary form of cancer immunotherapy that uses a patient's own genetically modified immune cells to fight cancer. We extract T-cells from the patient's blood through a process called leukapheresis and send them to a specialized laboratory. In the lab, these cells are genetically engineered to produce specific receptors on their surface called chimeric antigen receptors (CARs). These new receptors enable the T-cells to recognize and bind to specific proteins on the surface of cancer cells. Once the engineered cells are infused back into the patient, they multiply and launch a targeted attack to destroy the cancer cells throughout the body.

Which hospital is the best for CAR-T cell therapy in China?

When seeking the best clinical outcomes, SinoUnited Health stands out as one of the premier choices for international CAR-T cell therapy and cancer immunotherapy in China. Our specialized center is recognized as one of the first International Medical Tourism Pilot Demonstration Bases in Shanghai, offering seamless care for global patients. We operate as a key member unit of the Ruijin Hematology Medical Union and a construction unit of the Pan-Yangtze River Delta CAR-T Cell Therapy Alliance. This allows us to combine cutting-edge academic research with international standards of patient-centered clinical care. Our multidisciplinary team of experts ensures that every patient receives a highly personalized, safe, and world-class treatment experience.

Who is a suitable candidate for CAR-T cell therapy?

CAR-T cell therapy is primarily indicated for patients with relapsed or refractory B-cell malignancies, including certain types of leukemia, lymphoma, and multiple myeloma. Candidates typically undergo a rigorous pre-treatment evaluation to assess their overall physical health, organ function, and disease status. Our multidisciplinary medical team reviews each case thoroughly to determine if this advanced immunotherapy is the safest and most effective path forward. We also coordinate closely with international experts to obtain second opinions when managing complex or rare cases. Patients who have not responded to standard chemotherapy or stem cell transplants are often the primary candidates for this innovative treatment.

What does the treatment journey look like for international patients?

For international patients traveling to our Shanghai facility, we provide a fully integrated and supportive medical journey from start to finish. The process begins with a remote consultation and a comprehensive review of medical records to confirm eligibility before travel. Once the patient arrives, we assist with medical travel logistics, translation services, and comfortable inpatient accommodations. The clinical phase includes cell collection, a manufacturing period of three to four weeks, and the subsequent infusion followed by close inpatient monitoring. After discharge, we provide detailed recovery guidelines and coordinate with the patient's local physicians to ensure seamless post-treatment care.

How does the multidisciplinary team (MDT) model improve cancer care?

Our multidisciplinary team (MDT) model brings together specialists from oncology, hematology, pathology, radiology, and specialized nursing to collaborate on a single patient's care. Instead of receiving fragmented opinions, patients benefit from a unified, comprehensive treatment plan designed by multiple experts. This collaborative approach ensures that all aspects of the patient's physical and emotional health are addressed simultaneously. It significantly speeds up clinical decision-making, reduces the risk of complications, and optimizes the overall safety of complex therapies like CAR-T. By combining diverse medical expertise, we are able to deliver highly precise and personalized cancer care.

What safety measures are in place during the cell infusion and recovery phases?

Safety is our absolute priority, particularly during the critical infusion and immediate post-infusion recovery periods. Patients are monitored continuously in our state-of-the-art inpatient wards by a dedicated team of specialized oncology nurses and physicians. We are fully equipped to identify and manage potential side effects, such as Cytokine Release Syndrome (CRS) or neurological toxicities, using established international protocols. Our collaboration with top public medical unions ensures immediate access to advanced intensive care resources if required. We also provide comprehensive post-discharge guidelines and remote monitoring to support a safe and steady recovery.